(19)

(11)

EP 4 823 636 A1

(12)

(43) Date of publication: 21.10.2026 Bulletin 2026/43 (21) Application number: 24834865.8 (22) Date of filing: 13.12.2024

(51) International Patent Classification (IPC):  A61K 51/08(2006.01) A61K 31/7068(2006.01) A61P 35/00(2006.01) A61K 31/513(2006.01) A61K 45/06(2006.01) A61K 103/30(2006.01) (52) Cooperative Patent Classification (CPC): A61K 51/088; A61K 31/513; A61P 35/00; A61K 45/06; A61K 31/7068 (86) International application number: PCT/IB2024/062652 (87) International publication number: WO 2025/126151 (19.06.2025 Gazette 2025/25)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 15.12.2023 US 202363610502 P (71) Applicant: Novartis AG 4056 Basel (CH)	(72) Inventors: AIMONE, Paola Daniela 4056 Basel (CH) CACCIATORE, Silvia 4056 Basel (CH) CHERFI, Azzeddine 4056 Basel (CH) PERRAUD, Kevin 1204 Geneva (CH) (74) Representative: Ridout, Joseph  Novartis Pharma AG Patent Department Lichtstrasse 35 4056 Basel 4056 Basel (CH)